A study to evaluate efficacy and safety of a medication in adult and adolescent subjects with severe alopecia areata
The medication is already FDA approved since 2019 to treat other skin conditions
The study is intended to last about 3 years, including 16 clinic visits
Criteria:Be between 12 and 65 years of age
Have a diagnosis of Alopecia Areata at the beginning of the study